跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Imatinate - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Imatinate
Approved
STANDARD
Imatinate
Khandelwal Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
4be3c58c6aebb845
Company
Khandelwal Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
4be3c58c6aebb845
Drug Approval Philippines Name
Imatinate
Product Name
Imatinate
Registration Number
DRP-5035
Brand Name
Imatinate
Generic Name
Imatinib (as mesilate)
Dosage Form
Capsule
Dosage Strength
100 mg
Manufacturer
Khandelwal Laboratories Pvt. Ltd.
Importer
Medethix, Inc,
Distributor
Medethix, Inc,
Issuance Date
27 July 2023
Expiry Date
07 January 2029
Pharmacologic Category
Antineoplastic Agent
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
4be3c58c6aebb845
Type
Standard
Back to Philippines FDA Approvals